TrialEuropean journal of endocrinology2012

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial.

Leo Niskanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.